Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study

Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease

(2022) Carolina Lopez-Silva et al.   Clinical Journal of the American Society of Nephrology

Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients

(2021) Richard X. Liu et al.   Translational Research

Synergistic insights into human health from aptamer- and antibody-based proteomic profiling

(2021) Maik Pietzner et al.   Nature Communications

Comparison of Proteomic Assessment Methods in Multiple Cohort Studies

(2020) Laura M. Raffield et al.   PROTEOMICS

Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart Disease

(2020) Joseph Yang et al.   Journal of the American Heart Association

Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling

(2020) Agnese Petrera et al.   JOURNAL OF PROTEOME RESEARCH

Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma

(2019) Johannes Graumann et al.   Frontiers in Oncology

Plasma protein patterns as comprehensive indicators of health

(2019) Stephen A. Williams et al.   NATURE MEDICINE

Genomic atlas of the human plasma proteome

(2018) Benjamin B. Sun et al.   NATURE

Assessment of Variability in the SOMAscan Assay

(2017) Julián Candia et al.   Scientific Reports

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease

(2016) Kai C. Wollert et al.   CLINICAL CHEMISTRY

Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

(2014) Erika Assarsson et al.   PLoS One

Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery

(2011) Larry Gold et al.   PLoS One